A. Feiger

发表

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.

M. Jenike, M. Liebowitz, H. Akiskal, 1991, Archives of general psychiatry.

Interview quality and signal detection in clinical trials.

K. Kobak, J. Lipsitz, A. Feiger, 2005, The American journal of psychiatry.

The Rater Applied Performance Scale: development and reliability

K. Kobak, J. Lipsitz, A. Feiger, 2004, Psychiatry Research.

Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.

K. Rickels, M. Rynn, D. Zimbroff, 2006, The Journal of clinical psychiatry.

A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.

A. Feiger, 1996, Psychopharmacology bulletin.

The Rater AppliedPerformance Scale: d evelopment andreliability

K. Kobak, J. Lipsitz, A. Feiger, 2004 .

Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.

R. Shrivastava, A. Feiger, C. Wilcox, 1996, The Journal of clinical psychiatry.

A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.

A. Feiger, R. Rudolph, 1999, Journal of affective disorders.

Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.

R. Shrivastava, A. Feiger, K. Weiss, 2003, The Journal of clinical psychiatry.

Monkey motor stimulation and altered social behavior during chronic methadone administration

A. Feiger, T. Crowley, A. J. Stynes, 1975, Psychopharmacologia.

Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.

M. Trivedi, J. Bremner, R. Mcquade, 1999, International clinical psychopharmacology.

A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.

A. Feiger, A. Kiev, 1997, The Journal of clinical psychiatry.

Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double‐blind comparator studies

P. Boyer, M. Flament, A. Feiger, 2003, International clinical psychopharmacology.

A Placebo-Controlled Study Evaluating the Efficacy and Safety of Flexible-Dose Desvenlafaxine Treatment in Outpatients with Major Depressive Disorder

S. K. Padmanabhan, A. Feiger, K. Tourian, 2009, CNS Spectrums.

DNA Microarray Technology in the Clinical Environment: The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping

F. Chiafari, E. Pomarol-Clotet, Johnson, 2009, CNS Spectrums.

Development of a standardized training program for the Hamilton Depression Scale using internet-based technologies: results from a pilot study.

K. Kobak, J. Lipsitz, A. Feiger, 2003, Journal of psychiatric research.

Response to “Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression”

A. Feiger, R. Rudolph, 2001 .

Rating the Raters: Assessing the Quality of Hamilton Rating Scale for Depression Clinical Interviews in Two Industry-sponsored Clinical Drug Trials

Nina Engelhardt, Dawn Sikich, K. O. Cogger, 2006, Journal of clinical psychopharmacology.